Your browser doesn't support javascript.
loading
SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma.
Bill, Kate Lynn J; Garnett, Jeannine; Meaux, Isabelle; Ma, XiaoYen; Creighton, Chad J; Bolshakov, Svetlana; Barriere, Cedric; Debussche, Laurent; Lazar, Alexander J; Prudner, Bethany C; Casadei, Lucia; Braggio, Danielle; Lopez, Gonzalo; Zewdu, Abbie; Bid, Hemant; Lev, Dina; Pollock, Raphael E.
Afiliación
  • Bill KL; The Sarcoma Research Center, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences, Houston, Texas. Department of Surgical Oncology, Comprehensive Cancer Center, The Ohio State University (OSU), Columbus, Ohio.
  • Garnett J; The Sarcoma Research Center, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Meaux I; Sanofi Oncology, Vitry-sur-Seine, France.
  • Ma X; The Sarcoma Research Center, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Creighton CJ; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.
  • Bolshakov S; The Sarcoma Research Center, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Barriere C; Sanofi Oncology, Vitry-sur-Seine, France.
  • Debussche L; Sanofi Oncology, Vitry-sur-Seine, France.
  • Lazar AJ; The Sarcoma Research Center, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Prudner BC; Department of Surgical Oncology, Comprehensive Cancer Center, The Ohio State University (OSU), Columbus, Ohio.
  • Casadei L; Department of Surgical Oncology, Comprehensive Cancer Center, The Ohio State University (OSU), Columbus, Ohio.
  • Braggio D; Department of Surgical Oncology, Comprehensive Cancer Center, The Ohio State University (OSU), Columbus, Ohio.
  • Lopez G; Department of Surgical Oncology, Comprehensive Cancer Center, The Ohio State University (OSU), Columbus, Ohio.
  • Zewdu A; Department of Surgical Oncology, Comprehensive Cancer Center, The Ohio State University (OSU), Columbus, Ohio.
  • Bid H; Department of Surgical Oncology, Comprehensive Cancer Center, The Ohio State University (OSU), Columbus, Ohio.
  • Lev D; Department of Surgery, The Sheba Medical Center, Tel Aviv, Israel.
  • Pollock RE; The Sarcoma Research Center, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, Comprehensive Cancer Center, The Ohio State University (OSU), Columbus, Ohio. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston,
Clin Cancer Res ; 22(5): 1150-60, 2016 Mar 01.
Article en En | MEDLINE | ID: mdl-26475335
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Espiro / Proteína p53 Supresora de Tumor / Proteínas Proto-Oncogénicas c-mdm2 / Indoles / Liposarcoma / Recurrencia Local de Neoplasia Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Espiro / Proteína p53 Supresora de Tumor / Proteínas Proto-Oncogénicas c-mdm2 / Indoles / Liposarcoma / Recurrencia Local de Neoplasia Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos